Skip to main content
Howard Hochster, MD, Oncology, New Brunswick, NJ

Howard S Hochster MD

Oncology•New Brunswick, NJ

Gastrointestinal Cancer, Hematologic Oncology

Distinguished Professor of Medicine, Rutgers RWJ School of Medicine

Join to view full profile

  • 165 Somerset StreetNew Brunswick, NJ 08901

Dr. Hochster is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Hochster's full profileAlready have an account?

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1983 - 1986
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 1980 - 1983
  • Yale School of Medicine
    Yale School of MedicineClass of 1980

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2018 - 2027
  • CT State Medical License
    CT State Medical License 2010 - 2018
  • NY State Medical License
    NY State Medical License 1981 - 2016
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors for Cancer Castle Connolly, 2005-2019
  • America's Top Doctors Castle Connolly, 2004-2019
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma  
    Andrea Wang-Gillam, Howard S Hochster, JAMA Oncology
  • Association of Diet Quality with Survival Among People with Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial  
    Kimmie Ng, Chloe Atreya, Howard S Hochster, James N Atkins, Richard M Goldberg, Charles D Blanke, Jeffrey A Meyerhardt, JAMA Network Open
  • Antiangiogenesis in Early-Stage Colon Cancer—Microscopically Busted  
    Howard Hochster, MD, JAMA Network Open

Abstracts/Posters

  • A Multistate Survival Analysis for Patients with Follicular Lymphoma (FL) Using 13 First-Line Randomized Trials from FL Analysis of Surrogate Hypothesis (FLASH) Group
    Howard Hochster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Randomized trial of irinotecan and cetuximab (IC) versus irinotecan, cetuximab and ramucirumab (ICR) as 2nd line therapy of advanced colorectal cancer (CRC) following ... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/5/2018
  • Yale Cancer Center Evening Oncology Series: Gastrointestinal Cancers 
    Yale CME, New Haven, Connecticut - 9/20/2012

Press Mentions

  • Dramatic Rise in Gastrointestinal Cancers in People Under 50
    Dramatic Rise in Gastrointestinal Cancers in People Under 50July 17th, 2025
  • Gastrointestinal Cancers Are Rising Dramatically in People Under 50
    Gastrointestinal Cancers Are Rising Dramatically in People Under 50July 17th, 2025
  • How Many Patients in Early Cancer Trials Get Drugs Ultimately Approved by FDA?
    How Many Patients in Early Cancer Trials Get Drugs Ultimately Approved by FDA?March 7th, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Howard Hochster, Dr. Howard Hochster, MD, Dr. H Hochster, Dr. Howard S Hochster